Related Experiment Video
Updated: Jul 6, 2025
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
7.9K
Cellular proteins as potential targets for antiretroviral therapy
1I. Mechnikov Research Institute for Vaccines and Sera.
Voprosy Virusologii
|December 29, 2023
Summary
This review explores how host cell proteins, both HIV dependence and restriction factors, influence human immunodeficiency virus type 1 (HIV-1) replication. Understanding these interactions may lead to new therapeutic strategies targeting host factors for HIV treatment.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- The human immunodeficiency virus type 1 (HIV-1) lifecycle is intricately regulated by host cell factors.
- Understanding these host-pathogen interactions is crucial for developing effective antiviral therapies.
Approach:
- Comprehensive literature review of Scopus, Web of Science, and MedLine databases.
- Analysis of host cell proteins categorized as HIV dependence factors (e.g., CypA, LEDGF) and restriction factors (e.g., SERINC5, TRIM5α, APOBEC3G).
- Elucidation of the molecular mechanisms governing the function of these host factors in HIV-1 replication.
Key Points:
- Host dependence factors facilitate HIV-1 replication.
- Host restriction factors inhibit HIV-1 replication.
- Specific examples like CypA, LEDGF, SERINC5, TRIM5α, and APOBEC3G illustrate these roles.
Conclusions:
- Targeting host factors offers a promising strategy for novel HIV-1 therapeutics.
- Drugs could be developed to inhibit detrimental host factors or enhance beneficial ones.
- Further research into host factor modulation holds potential for advancing HIV treatment.
